Health
Monoclonal antibodies can help high-risk people with COVID-19. But getting the drug to patients remains challe – The Philadelphia Inquirer
Demand for the drugs, which are the only approved treatment for high-risk patients who don’t need to be in the hospital, is lower than expected.
Back in December, the big worry about two newly approved treatments for early COVID-19 was that demand would far outstrip supply.
After all, some famous men had taken monoclonal antibodies after they were infected in the fall some of them before the drugs received emergency-use authorization and became highly visible converts.
Former President Donald Trump called a drug made by Regeneron a cure. (He was also given other treatments that may have helped him recover.) Ben Carson, former secretary of…
-
Noosa News19 hours agoDaly Cherry-Evans set to be dropped as Maroons captain
-
Noosa News18 hours agoThe Story Bridge should serve as a warning – and an opportunity
-
General18 hours agoHundreds gather in Gin Gin at vigil for allegedly murdered teen Pheobe Bishop
-
General22 hours agoAFL round 13 live: North Melbourne vs West Coast, Carlton vs Essendon updates, scores and highlights